Pharmides SRL
The score of Pharmides shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +289 % Total assets +278 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmides's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
Pharmides's financial analysis
- Solvency96.0%sector median: 61.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmides
Pharmides's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0781.475.649
- VAT number
- BE0781475649
- Peppol
- Registered · 0208:0781475649 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Feb 2022
- Registered office
- 3900 Pelt
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Research and experimental development on social sciences and humanities (NACE 72200)
Pharmides (SRL) has been based in Pelt since 2022, active in: research and experimental development on social sciences and humanities. For 2025, it reports a net profit of 30,503 € and equity of 115,992 €; its revenue is not published. Its solvency stands at 96.0%, above the median of its sector (61.8%).
Companies similar to Pharmides
Companies in the same business, of comparable size and area, outside its group.
- Serin-BE Research and experimental development on social sciences and humanities Limbourg · balance sheet 158,896 €
- LISN Research and experimental development on social sciences and humanities Hélécine · balance sheet 51,223 €
- CVDH – Therapie & Consult Research and experimental development on social sciences and humanities Genk · balance sheet 110,115 €
- icode Research and experimental development on natural sciences and engineering Walhain · balance sheet 79,376 €
- Synaptic Input Research and experimental development on social sciences and humanities Sint-Pieters-Leeuw · balance sheet 80,015 €
- Industrial Futur Research and experimental development on social sciences and humanities Namur · balance sheet 144,471 €
- HET Lampje Research and experimental development on social sciences and humanities Leuven · balance sheet 118,562 €
- Think Process Research and experimental development on social sciences and humanities Saint-Gilles · balance sheet 278,660 €
Frequently asked questions about Pharmides
What is the revenue of Pharmides?
Pharmides files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmides?
In Belgium, the VAT number is the company number prefixed with BE: BE0781475649 for Pharmides, if the company is VAT-registered. Its company number (CBE) is 0781.475.649.
Where is the registered office of Pharmides?
According to the CBE register, the registered office of Pharmides is in 3900 Pelt.
What is the equity of Pharmides?
At the close of the 2025 financial year, the equity of Pharmides amounts to 115,992 €, a solvency of 96.0% of total assets.
Who manages Pharmides?
The register lists 1 active mandates at Pharmides. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmides
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →